Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Bisogno

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 8, 1998
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferationL De Petrocellis, D Melck, A Palmisano, et al.
Endocrinology|December 30, 1999
Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferationD Melck, L De Petrocellis, P Orlando, et al.
Biochemical and Biophysical Research Communications|August 17, 1999
Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptorsD Melck, T Bisogno, L De Petrocellis, et al.
Andrology|November 19, 2016
2-arachidonoylglycerol levels are increased in leukocytospermia and correlate with seminal macrophagesA Barbonetti, T Bisogno, N Battista, et al.
The Journal of Biological Chemistry|March 30, 2001
The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolismL De Petrocellis, T Bisogno, M Maccarrone, et al.
European Journal of Biochemistry|August 14, 1999
Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophagesV Di Marzo, T Bisogno, L De Petrocellis, et al.
European Journal of Biochemistry|March 30, 2001
The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptorsT Bisogno, M MacCarrone, L De Petrocellis, et al.
Biochemical and Biophysical Research Communications|March 18, 1999
Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological functionT Bisogno, F Berrendero, G Ambrosino, et al.
FEBS Letters|November 4, 1998
Interactions between synthetic vanilloids and the endogenous cannabinoid systemV Di Marzo, T Bisogno, D Melck, et al.
The Biochemical Journal|October 24, 2000
N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivoT Bisogno, D Melck, Bobrov MYu, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Proceedings of the National Academy of Sciences of the United States of America|July 8, 1998
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferationL De Petrocellis, D Melck, A Palmisano, et al.
Endocrinology|December 30, 1999
Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferationD Melck, L De Petrocellis, P Orlando, et al.
Biochemical and Biophysical Research Communications|August 17, 1999
Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptorsD Melck, T Bisogno, L De Petrocellis, et al.
Andrology|November 19, 2016
2-arachidonoylglycerol levels are increased in leukocytospermia and correlate with seminal macrophagesA Barbonetti, T Bisogno, N Battista, et al.
The Journal of Biological Chemistry|March 30, 2001
The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolismL De Petrocellis, T Bisogno, M Maccarrone, et al.
European Journal of Biochemistry|August 14, 1999
Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophagesV Di Marzo, T Bisogno, L De Petrocellis, et al.
European Journal of Biochemistry|March 30, 2001
The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptorsT Bisogno, M MacCarrone, L De Petrocellis, et al.
Biochemical and Biophysical Research Communications|March 18, 1999
Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological functionT Bisogno, F Berrendero, G Ambrosino, et al.
FEBS Letters|November 4, 1998
Interactions between synthetic vanilloids and the endogenous cannabinoid systemV Di Marzo, T Bisogno, D Melck, et al.
The Biochemical Journal|October 24, 2000
N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivoT Bisogno, D Melck, Bobrov MYu, et al.
Pageof 7